Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9481223 | 0.81 | — | — | |
| SCHEMBL7439614 | 0.79 | ADRA2A (0.37) | ALDH1A1POLB | |
| SCHEMBL9521455 | 0.79 | MGAM (0.43) | ALDH1A1POLB | |
| SCHEMBL10403259 | 0.77 | ALDH1A1 (0.32) | ALDH1A1POLB | |
| SCHEMBL10403258 | 0.77 | ALDH1A1 (0.32) | ALDH1A1POLB | |
| SCHEMBL2171695 | 0.77 | TSHR (0.32) | ALDH1A1POLB | |
| SCHEMBL10105403 | 0.75 | TSHR (0.40) | ALDH1A1POLB | |
| SCHEMBL6447039 | 0.75 | NAAA (0.41) | ALDH1A1POLB | |
| SCHEMBL3042462 | 0.75 | ALDH1A1 (0.31) | ALDH1A1POLB | |
| SCHEMBL7820387 | 0.75 | HTT (0.50) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6475955-B2 | HERBICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-11-05 | — | — | US | disclosed |
| US-20020026048-A1 | Pyridazinone derivatives | SUMITOMO CHEMICAL CO. LTD. | 2002-02-28 | — | — | US | disclosed |
| US-6187920-B1 | HERBICIDES | SUMITOMO CHEMICAL CO., LTD. (JP) | 2001-02-13 | — | — | US | disclosed |
| WO-2000021936-A1 | URACIL HERBICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-04-20 | — | — | WO | disclosed |
| EP-0947509-A2 | Pyridazinone derivatives | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-10-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020026048-A1 | Pyridazinone derivatives | PDXK, DDT, CBR3 | ALDH1A1 105/4885POLB 2912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.